TOP2 anticorps (C-Term)
-
- Antigène Voir toutes TOP2 Anticorps
- TOP2 (DNA Topoisomerase II (TOP2))
-
Épitope
- C-Term
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp TOP2 est non-conjugé
-
Application
- Western Blotting (WB), ELISA
- Réactivité croisée
- Humain
- Réactivité croisée (Details)
- Calculated cross reactivity: Hu
- Attributs du produit
- Topoisomerase II (DNA) alpha
- Purification
- Purified by immunoaffinity chromatography.
- Immunogène
- 18aa peptide from ~C-terminus of human Topoisomerase II alpha. Sequence is 100% conserved in alternatively spliced isoforms 2-4 of human TOP2A.
- Clone
- 7C52
- Isotype
- IgG
- Top Product
- Discover our top product TOP2 Anticorps primaire
-
-
- Indications d'application
- Optimal working conditions should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Buffer
- Supplied as a lyophilized powder from PBS, 0.05 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- -20°C
-
- Antigène
- TOP2 (DNA Topoisomerase II (TOP2))
- Abstract
- TOP2 Produits
- Synonymes
- anticorps Topoii, anticorps ptr11, anticorps DDBDRAFT_0191045, anticorps DDBDRAFT_0231510, anticorps DDB_0191045, anticorps DDB_0231510, anticorps CG10223, anticorps CHRAC, anticorps Dmel\\CG10223, anticorps TOP2, anticorps TOPO II, anticorps TOPOII, anticorps TopII, anticorps Topo II, anticorps TopoII, anticorps dCHRAC, anticorps dTopoII, anticorps top2, anticorps topo II, anticorps topoII, anticorps topoisomerase II, anticorps DNA topoisomerase II, anticorps DNA topoisomerase 2, anticorps DNA topoisomerase ii, anticorps type IIA topoisomerase; DNA gyrase topoisomerase IV B subunit, anticorps Topoisomerase 2, anticorps TOP2, anticorps A583L, anticorps top2, anticorps CNA03600, anticorps Tb09.160.4090, anticorps Tb11.01.3390, anticorps LMJF_28_2280, anticorps Top2
- Pathways
- Mitotic G1-G1/S Phases
-